Tetratherix logo

Tetratherix(ASX) TTX

Market CapA$336.44MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)+110%
5 YearN/A
1 Year+55%
1 Month-13%
A$6.34
-6.07%
-0.41Today
Tetratherix last closing stock price
MetricPriceDate
Last closeAUD 6.342026-10-09
Tetratherix stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.71%AUD 6.452026-10-02
1 month-13.27%AUD 7.312026-09-09
3 month+1.44%AUD 6.252026-07-10
Year to date+93.29%AUD 3.282025-12-30
1 year+54.63%AUD 4.102025-10-09
Since inception+109.93%AUD 3.022025-06-30

Tetratherix Financials at a Glance

Market Cap

A$336.44MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-A$0.18

P/E Ratio

-35.14

Dividend

A$0.00

Beta (Volatility)

0.52 (Low)

Price

A$6.34

Volume

14,377

Open

A$6.70

Previous Close

A$6.34

Daily Range

A$6.34 - A$6.75

52-Week Range

A$3.09 - A$8.08

Estimated Earnings Date

Mar 1, 2027

TTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tetratherix

Tetratherix Ltd. is a biotechnology company based in Alexandria, Australia, specializing in biomaterials and regenerative medicine. Established in 2015, the company focuses on developing innovative products using its proprietary Tetramatrix platform technology for applications in bone regeneration and advanced tissue healing.

Products and Services
  • Bone regeneration solutions utilizing Tetramatrix technology
  • Tissue spacing products for enhanced healing
  • Advanced tissue healing applications for various medical needs
Growth Outlook
  • Significant market potential in regenerative medicine sector
  • Expansion into international markets to drive revenue growth
  • Continued investment in R&D to enhance product offerings
Financial Highlights
  • Market capitalization of approximately AUD 326 million
  • Stock price range between AUD 3.09 and AUD 8.08 over the past year
  • Beta of 1.635 indicates higher volatility compared to the market
Tetratherix Ltd. operates in a rapidly growing industry with a focus on innovative solutions for medical applications. The company's proprietary technology positions it well to capitalize on the increasing demand for regenerative medicine products. With a solid market capitalization and a strategic focus on research and development, Tetratherix is poised for future growth and expansion. The stock's performance over the past year reflects its potential, making it an interesting option for investors looking at the biotechnology sector.
AI Generated • Sep 21, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Will Knox

Website

tetratherix.com

Headquarters

Alexandria, NSW 2015, AU

TTX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-31.08%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-2.85%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

A$336.44MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

53.07M

Volume

14.38K

Avg. Volume

24.58K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Tetratherix Performance Analysis

Tetratherix annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 0N/A
20242024-06-30AUD 33,956N/A
20252025-06-30AUD 0N/A
20262026-06-30AUD 918,151N/A
Tetratherix annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.0418.7%
20242024-06-30AUD -0.0540.1%
20252025-06-30AUD -0.19269.4%
20262026-06-30AUD -0.18-6.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

A$336.44MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OCC.AXOrthocell Limited
A$0.69-0.72%
ARX.AXAroa Biosurgery Limited
A$0.52+0.00%
PNV.AXPolyNovo Limited
A$0.94+1.63%
TRP.AXTissue Repair Ltd
A$0.09+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.18-9.81%
WFFWf
$12.29+499.51%
VZVerizon Communications
$41.65-8.75%
SPCXSpace Exploration Technologies
$162.57+1.25%

Questions About TTX

What is the current price of Tetratherix?

Tetratherix is trading at A$6.34 per share.

What is the 52-week range for Tetratherix?

Over the past 52 weeks, Tetratherix has traded between A$3.09 and A$8.08.

How much debt does Tetratherix have?

As of the most recent reporting period, Tetratherix reported total debt of A$10.97M.

How much cash does Tetratherix have on hand?

Tetratherix reported A$34.36M in cash and cash equivalents in its most recent financial results.

What is Tetratherix’s dividend yield?

Tetratherix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services